PharmaSwiss is developing a growing portfolio of
pharmaceutical products to meet some of the most urgent & unmet medical needs in
the region where it operates.
With our product portfolio focused in 7
therapeutic areas (heart and circulatory diseases, pain management,
anti-infectives, rheumatic diseases, neurological and psychiatric conditions,
oncology, gastroenterology), PharmaSwiss helps to stop further development,
treat& and prevent many of the most common, and most challenging medical
conditions of nowadays society. In addition, PharmaSwiss is dedicated to improve
the lives of patients with many other diseases, including metabolic disorders,
different skin conditions, pediatric diseases, women’s health and urological
Some of our OTC brands, such as Cardiopirin,
Mucopront, OmegaDefend, Mamavit, DicloFlex, Swiss Relief Spray Gel, Rapidol and
many others are already very well known to the customers in our region. The OTC
part of our product portfolio brings an additional dynamic dimension to our
company, but, as for all of our products, evidence-based medicine is always
behind our OTC brands.
Our intention is also to create partnerships with
healthcare professionals and customers to ensure access to our products, but to
educate and empower consumers, too.
Year by year, our products help saving and improving
the lives of millions of people. We are proud of our history of bringing
new products & innovative formulations to our markets.
Please be aware that some of our products being in
various stages of regulatory approval around the region of Central and Eastern
Europe, Greece and Israel and might not yet be available in every country.
The Product section of PharmaSwiss Web site presented
here is intended for use in the region of Central and Eastern Europe, Greece and
Israel, where PharmaSwiss is present with these products. Other countries may
have different regulatory requirements and review practices that may require
referencing different information.